VasQ and A
The FDA has approved VasQ, a new device to reduce fistula failure, for a 2-year clinical trial with 129 patients. The device keeps fistulas from growing too large by providing an external support.
Read the full article » | Posted 08-17-2017
- New Measure of Home Dialysis Dropout Posted 01-16-2024
- Check out the NextKidney Neokidney HD Machine Posted 11-15-2023
- New Redsense Clamp Add-on Will Stop the Blood Pump! Posted 10-13-2023
- AWAK Technologies Raised Another $20 million for Shoulder Bag Sized Wearable PD Posted 10-13-2023